Aardvark Therapeutics is a San Diego biopharmaceutical company developing oral medicines that aim to reduce hunger in metabolic conditions. It last closed at $0.92 on Nov 20, down 7.74% on the day. The next earnings report for AARD is expected around Mon, Mar 22, 2027, after the close. For the quarter ended Sep 2026, AARD reported EPS of -$0.88 on revenue of $0. Over its last 8 reports the stock moved an average of 7.1% the session after earnings. Over the last 12 months AARD insiders bought $145K of stock on the open market and sold $395K, according to SEC Form 4 filings.
AI Auto Pilots
Is AARD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold AARD.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on AARDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
AARD · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 36% below its 20 day and 263% below its 50 day average. It is 481% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the 52 week low at $0.90, and the nearest resistance the Pivot at $0.96.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 34.7%/day
Key levels
$16.6052 week high+1704.3%
$5.36200 day average+482.6%
$4.82100 day average+423.9%
$3.3550 day average+264.1%
$1.70Swing high (Nov 13)+84.8%
$1.2520 day average+35.9%
$1.02Pivot R1+10.9%
$0.96Pivot+4.3%
$0.92Last close
$0.9052 week low−2.2%
$0.86Pivot S1−6.5%
Indicators
RSI (14)
28.66
Oversold below 30
Oversold
MACD
-0.65
Above its signal line
Bullish
Stochastic
5.0
Near the bottom of its range
Oversold
ADX (14)
43.8
Strong downtrend
Williams %R
-97.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-153.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−21.1%
Change over 10 sessions
Bearish
ATR (14)
$0.32
Typical daily range, 34.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 135.6%/day
Key levels
$16.6052 week high+1704.3%
$5.36200 day average+482.6%
$4.82100 day average+423.9%
$3.3550 day average+264.1%
$1.70Swing high (Nov 13)+84.8%
$1.2520 day average+35.9%
$1.02Pivot R1+10.9%
$0.96Pivot+4.3%
$0.92Last close
$0.9052 week low−2.2%
$0.86Pivot S1−6.5%
Indicators
RSI (14)
28.42
Oversold below 30
Oversold
MACD
-1.45
Below its signal line
Bearish
Stochastic
3.2
Near the bottom of its range
Oversold
ADX (14)
21.9
Weak trend
Williams %R
-99.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-143.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−82.0%
Change over 10 sessions
Bearish
ATR (14)
$1.25
Typical daily range, 135.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for AARD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AARD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for AARDHow many large options trades hit AARD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in AARD in the last 90 days.
From SEC Form 4 filings by AARD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AARD is in one of them and how their past AARD trades turned out.
Aardvark Therapeutics is a biopharmaceutical company based in San Diego, California, that develops small molecule medicines aimed at reducing hunger. Its work centers on compounds that act on bitter taste receptors in the gut, which are designed to prompt the body to release its own appetite-related hormones. Its lead candidate, ARD-101, is an oral drug being studied for hyperphagia, an extreme hunger condition associated with Prader-Willi syndrome. The company has no approved products yet and aims to serve patients with metabolic conditions and the clinicians who treat them.